Obsessive-compulsive disorder affects millions of adults and is among the more misunderstood psychiatric conditions in both clinical and public contexts — frequently reduced to personality quirks about cleanliness or order when the clinical reality involves persistent, unwanted intrusive thoughts and compulsive behaviors that can consume hours of a person’s day and significantly impair functioning. For patients whose OCD has not responded adequately to first-line treatments, emerging research supported by the National Institutes of Health has identified ketamine as a treatment showing meaningful promise. At Mend The Mind in Livingston, Montana, we offer IV ketamine therapy for adults with OCD as part of our comprehensive treatment approach.
What OCD Actually Is
Obsessive-compulsive disorder (OCD) is a psychiatric condition characterized by two core features: obsessions and compulsions. Obsessions are persistent, unwanted, intrusive thoughts, images, or urges that cause significant distress — not thoughts a person chooses to have, but thoughts that force their way into awareness and resist being dismissed. Compulsions are repetitive behaviors or mental acts performed in response to obsessions, driven by a need to reduce anxiety, prevent a feared outcome, or restore a sense of control. According to Mayo Clinic, common obsession themes include fears of contamination, harm, symmetry, and forbidden thoughts, while compulsions can involve checking, cleaning, counting, arranging, or seeking reassurance.
The National Institute of Mental Health describes OCD as a condition in which the cycle of obsessions and compulsions can become consuming and deeply disruptive — far removed from the casual use of “OCD” in everyday language. For many patients, the condition is chronic, waxing and waning rather than resolving, and it carries significant impact on work, relationships, and quality of life. The degree of insight patients have about their obsessions varies: some recognize clearly that their fears are disproportionate to reality; others experience genuine uncertainty that makes the compulsive response feel genuinely necessary.
Understanding OCD on its own terms — not as a personality trait or a preference for tidiness, but as a neurological condition involving specific, dysfunctional circuits — is the foundation for understanding why certain treatment approaches work and others do not.
Why OCD Resists Standard Treatment
First-line treatments for OCD include specific antidepressants — typically SSRIs (selective serotonin reuptake inhibitors) at higher doses than those used for depression — and cognitive behavioral therapy (CBT), particularly a specific form called exposure and response prevention (ERP). According to the National Institute of Mental Health, these treatments are effective for many patients and represent the established standard of care.
For a clinically significant subset, however, response to first-line treatment is partial or absent. Some patients cannot tolerate the doses of SSRIs required for OCD response due to side effects. Others complete exposure-based therapy and achieve some reduction in symptoms without reaching a level of functioning that feels meaningfully restored. And for patients with severe, chronic OCD, the treatment burden of ongoing ERP — which requires deliberate, repeated exposure to distressing triggers without performing compulsions — can be genuinely difficult to sustain without additional neurobiological support.
These patients represent the population for whom emerging treatments like ketamine therapy are most clinically relevant. The question is not whether first-line treatment should be attempted — it should — but what options exist for patients who have attempted it and found it insufficient.
What the Evidence Shows for Ketamine and OCD
The evidence base for ketamine in OCD is earlier-stage than for depression or PTSD, but it is meaningful and has attracted attention from federal research institutions. Research highlighted by the National Institutes of Health identifies ketamine as showing promise for patients with OCD who have not responded to standard treatments — an acknowledgment from a major federal health body that positions this as a legitimate area of emerging clinical inquiry rather than fringe experimentation.
The mechanism by which IV ketamine may help OCD involves its action on NMDA receptors — N-methyl-D-aspartate receptors — in the glutamate system, the brain’s primary excitatory neurotransmitter network. Standard OCD treatments target serotonin pathways. Ketamine targets glutamate, a neurotransmitter involved in the rigidity of neural circuits — the well-worn pathways that sustain obsessive thought patterns and compulsive responses. By modulating the glutamate system and promoting neuroplasticity — the brain’s capacity to form new neural connections and reorganize existing ones — ketamine may help disrupt the rigid circuitry that sustains the OCD cycle in ways that serotonin-targeting medications cannot.
The evidence for ketamine in OCD consists primarily of early-stage and emerging research. We present it as such. What the research supports is that ketamine may offer meaningful relief for some patients with treatment-resistant OCD — not that it is a proven cure or that it produces uniform results across this population. Individual results vary, and we discuss the current state of the evidence honestly during every evaluation.
What Treatment Looks Like at Mend The Mind for OCD
Every patient evaluated for ketamine therapy at Mend The Mind begins with a comprehensive assessment. For OCD specifically, this includes a review of which treatments you have previously tried — which SSRIs, at what doses and for how long, and whether you have completed a course of ERP or CBT — as well as how you responded and what your current symptom picture looks like. This history informs whether ketamine therapy is an appropriate option for your situation and what realistic expectations for your response might be. OCD is one of the conditions we evaluate for across our full scope of adult psychiatric care.
IV ketamine infusions are administered in a private, comfortable treatment room in Livingston by our founder Cassidy Boyer, a Board Certified Registered Nurse Anesthesiologist and PMHNP candidate completing her post-master’s training at Montana State University. Every session includes continuous monitoring of heart rate, blood pressure, and oxygen levels throughout the infusion, and Cassidy is present from start to recovery. Our standard initial protocol is six infusions over two to three weeks.
For patients who establish response through an initial IV series and are seeking ongoing support, we prescribe ketamine troches — at-home dissolvable lozenges under ongoing medical supervision. This option can be particularly relevant for OCD patients who benefit from sustained, lower-intensity ketamine exposure to maintain reductions in symptom intensity between IV sessions. Discuss with your provider whether troches are an appropriate part of your long-term plan.
Addressing Fear of the Treatment Itself
OCD can create a specific and layered barrier to seeking treatment: the condition itself may generate intrusive thoughts about treatment, fears about medication effects, or doubt-based compulsions that make it difficult to commit to a course of care without extensive reassurance-seeking. We see this in patients who have thoroughly researched ketamine therapy, who intellectually understand the rationale, and who nonetheless find themselves stuck in a loop of uncertainty that delays the first consultation.
We do not approach this barrier with impatience. The double bind of a condition that makes it harder to seek treatment for itself is a real clinical phenomenon, not a sign that a patient is not serious about getting better. If OCD-driven uncertainty or reassurance-seeking is part of what is making it difficult to move forward, naming that in your consultation is a useful starting point. We are prepared for that conversation.
For patients who have concerns about the ketamine experience itself — the dissociation, the altered perception, the loss of ordinary cognitive control — we discuss what the experience is genuinely like in detail before any treatment begins. Research from the National Institutes of Health confirms that side effects from antidepressant-dose IV ketamine are generally mild and brief. That clinical record is worth knowing before fear of the unknown becomes a barrier to care.
Addressing Cost
Pricing at Mend The Mind is discussed during your consultation rather than published on our website. Treatment plans are individualized, and a published figure would not accurately represent what your specific plan involves. We are an out-of-network provider. Through the Osmind care management platform, every patient receives a detailed superbill following each session that can be submitted to their insurance company for potential reimbursement. Coverage outcomes vary significantly by plan. We recommend contacting your insurer before your consultation to ask specifically about out-of-network benefits for ketamine therapy.
We do not want cost to be a silent barrier that prevents a patient who might benefit from treatment from pursuing an evaluation. We are willing to have that conversation directly and early.
Frequently Asked Questions
Is ketamine therapy for OCD experimental?
Ketamine for OCD is an area of emerging rather than established research. The evidence base is earlier-stage than it is for depression or PTSD, and we present it that way. What the research supports is meaningful promise for patients who have not responded to standard treatments — not proven efficacy across the full OCD population. We discuss the current state of the evidence honestly during your evaluation so you can make an informed decision.
Do I need to stop my current OCD medications before starting ketamine therapy?
This depends on which medications you take. Some can continue alongside ketamine therapy; others may require adjustment. Your current medication list is reviewed thoroughly during your evaluation. Do not adjust or discontinue any medications without guidance from your prescribing provider.
Can ketamine therapy replace ERP therapy for OCD?
Ketamine therapy addresses the neurobiological dimensions of OCD and may reduce symptom intensity in ways that make other therapeutic work more accessible. It is not a replacement for evidence-based behavioral therapy. For patients who have found ERP difficult to sustain or complete due to symptom severity, ketamine may help create a more tractable starting point — but the behavioral and psychological dimensions of OCD benefit from appropriate therapeutic support alongside any biological intervention.
How variable are results for OCD compared to depression?
The research on ketamine and OCD shows variable results, with some patients experiencing significant symptom reduction and others seeing modest improvement. Response to ketamine for OCD is less predictable than for depression, and we discuss that honestly during your evaluation. Results vary by individual, and realistic expectations are part of every candidacy conversation at Mend The Mind.
Will ketamine therapy help with the anxiety component of my OCD?
OCD frequently co-occurs with anxiety, and ketamine has shown effectiveness for anxiety disorders in the research literature. Whether treatment addresses both dimensions of your presentation is something we discuss during your evaluation, accounting for your full clinical picture rather than a single diagnosis.
Key Takeaways
- OCD is a neurological condition characterized by intrusive obsessions and compulsive responses — not a personality trait — and it resists first-line treatment in a clinically significant subset of patients who need a different approach.
- Emerging research highlighted by the National Institutes of Health identifies ketamine as a promising option for patients with OCD who have not responded to standard treatments, working through the glutamate system rather than serotonin pathways.
- Ketamine’s action on NMDA receptors and its promotion of neuroplasticity may help disrupt the rigid neural circuitry sustaining the OCD cycle — a mechanism distinct from every medication in the standard OCD treatment stack.
- At Mend The Mind, IV ketamine therapy for OCD follows a six-infusion initial protocol with ketamine troches available as a maintenance option; all treatment decisions are grounded in your specific history and the current state of the evidence.
- Results vary by individual. The evidence for ketamine in OCD is early-stage, and honest representation of that evidence base is a consistent part of how we discuss this treatment with patients.
Conclusion
OCD that has not responded to standard treatment is not a condition that has exhausted all options — the evidence supporting ketamine therapy as a next step for this population, while still emerging, is grounded in credible research and warrants serious consideration for patients who have found conventional approaches insufficient. Results vary by individual, and an honest evaluation of your specific history is the right starting point. At Mend The Mind in Livingston, we are equipped to have that conversation and to give you a direct assessment of whether IV ketamine therapy is appropriate for your situation across the full range of conditions we treat. Call us at 406-350-4439, email mendthemindmt@gmail.com, or request a consultation through our website.
References
National Institutes of Health. Ketamine for OCD. https://nihrecord.nih.gov/2023/01/06/new-treatments-ocd-show-promise
Mayo Clinic. Symptoms of OCD. https://www.mayoclinic.org/diseases-conditions/obsessive-compulsive-disorder/symptoms-causes/syc-20354432
National Institute of Mental Health. What is OCD. https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy for OCD should only be pursued under the supervision of a qualified, licensed healthcare provider who is familiar with your full medical and psychiatric history. Individual results vary, and Mend The Mind does not guarantee specific outcomes from any treatment. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency room.